This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Jul 10;371(2):175-6.

doi: 10.1056/NEJMe1405746.

Hormone therapy in premenopausal women with early-stage breast cancer

Affiliations

PMID: 25006724
DOI: 10.1056/NEJMe1405746

Editorial

Hormone therapy in premenopausal women with early-stage breast cancer

Hope S Rugo. N Engl J Med. 2014.

. 2014 Jul 10;371(2):175-6.

doi: 10.1056/NEJMe1405746.

Author

Affiliation

¹ From the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco.

PMID: 25006724
DOI: 10.1056/NEJMe1405746

No abstract available

PubMed Disclaimer

Comment on

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group. Pagani O, et al. N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881463 Free PMC article. Clinical Trial.

Similar articles

Exemestane with ovarian suppression in premenopausal breast cancer.
Prasad V. Prasad V. N Engl J Med. 2014 Oct 2;371(14):1358. doi: 10.1056/NEJMc1409366. N Engl J Med. 2014. PMID: 25271613 No abstract available.
Exemestane with ovarian suppression in premenopausal breast cancer.
Chlebowski RT, Pan K. Chlebowski RT, et al. N Engl J Med. 2014 Oct 2;371(14):1358. doi: 10.1056/NEJMc1409366. N Engl J Med. 2014. PMID: 25271612 No abstract available.
Exemestane with ovarian suppression in premenopausal breast cancer.
Amoroso V, Berruti A, Simoncini E. Amoroso V, et al. N Engl J Med. 2014 Oct 2;371(14):1357. doi: 10.1056/NEJMc1409366. N Engl J Med. 2014. PMID: 25271611 No abstract available.
Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.
Frampton JE. Frampton JE. Drugs. 2017 Dec;77(18):2037-2048. doi: 10.1007/s40265-017-0849-3. Drugs. 2017. PMID: 29177573 Review.
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer.
Conte B, Poggio F, Del Mastro L. Conte B, et al. Expert Opin Pharmacother. 2017 Sep;18(13):1357-1362. doi: 10.1080/14656566.2017.1363181. Epub 2017 Aug 10. Expert Opin Pharmacother. 2017. PMID: 28764603 Review.

See all similar articles

Cited by

Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C, Liu Y, Zhou M, Wang W, Shi M, Xing M, Liao W. Pan C, et al. Int J Nanomedicine. 2018 Feb 27;13:1119-1137. doi: 10.2147/IJN.S147464. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29520140 Free PMC article.
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway.
Qin G, Xu F, Qin T, Zheng Q, Shi D, Xia W, Tian Y, Tang Y, Wang J, Xiao X, Deng W, Wang S. Qin G, et al. Oncotarget. 2015 Dec 8;6(39):41794-808. doi: 10.18632/oncotarget.5993. Oncotarget. 2015. PMID: 26540629 Free PMC article.
Targeted delivery of paclitaxel by functionalized selenium nanoparticles for anticancer therapy through ROS-mediated signaling pathways.
Gong G, Fu B, Ying C, Zhu Z, He X, Li Y, Shen Z, Xuan Q, Huang Y, Lin Y, Li Y. Gong G, et al. RSC Adv. 2018 Nov 30;8(70):39957-39966. doi: 10.1039/c8ra07539e. eCollection 2018 Nov 28. RSC Adv. 2018. PMID: 35558255 Free PMC article.
Heme Oxygenase-1 Inhibits Tumor Metastasis Mediated by Notch1 Pathway in Murine Mammary Carcinoma.
Li Q, Liu Q, Cheng W, Wei H, Jiang W, E F, Yu Y, Jin J, Zou C. Li Q, et al. Oncol Res. 2019 Jun 21;27(6):643-651. doi: 10.3727/096504018X15415906335771. Epub 2019 Feb 14. Oncol Res. 2019. PMID: 30764900 Free PMC article.
Clinical utilities of aromatase inhibitors in breast cancer.
Chumsri S. Chumsri S. Int J Womens Health. 2015 May 6;7:493-9. doi: 10.2147/IJWH.S69907. eCollection 2015. Int J Womens Health. 2015. PMID: 26005359 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information